Dyson T. Wake

830 total citations
13 papers, 358 citations indexed

About

Dyson T. Wake is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dyson T. Wake has authored 13 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dyson T. Wake's work include Pharmacogenetics and Drug Metabolism (10 papers), Pharmaceutical studies and practices (6 papers) and Genomics and Rare Diseases (3 papers). Dyson T. Wake is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Pharmaceutical studies and practices (6 papers) and Genomics and Rare Diseases (3 papers). Dyson T. Wake collaborates with scholars based in United States. Dyson T. Wake's co-authors include Henry M. Dunnenberger, D. Max Smith, Peter J. Hulick, Amy A. Lemke, Nicole Glaser, Sadaf Kazi, Christina G. Selkirk, Kristin Weitzel, Yan Gong and Amanda R. Elsey and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Genetics in Medicine and Frontiers in Genetics.

In The Last Decade

Dyson T. Wake

13 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dyson T. Wake United States	8	241	165	74	61	56	13	358
Carolyn R. Rohrer Vitek United States	12	267 1.1×	158 1.0×	85 1.1×	109 1.8×	52 0.9×	17	398
Emily J. Cicali United States	9	170 0.7×	99 0.6×	33 0.4×	36 0.6×	33 0.6×	28	261
Kenneth D. Levy United States	7	138 0.6×	107 0.6×	89 1.2×	116 1.9×	71 1.3×	13	301
Amanda R. Elsey United States	13	481 2.0×	311 1.9×	131 1.8×	163 2.7×	118 2.1×	20	775
Kristin Wiisanen United States	9	162 0.7×	88 0.5×	34 0.5×	33 0.5×	25 0.4×	20	213
Kristine Ashcraft United States	7	210 0.9×	136 0.8×	23 0.3×	57 0.9×	56 1.0×	11	315
Anne‐Marie Buunk Netherlands	7	200 0.8×	100 0.6×	19 0.3×	33 0.5×	23 0.4×	7	303
P Madadi Canada	5	130 0.5×	168 1.0×	79 1.1×	33 0.5×	8 0.1×	5	293
Leland E. Hull United States	9	112 0.5×	86 0.5×	46 0.6×	104 1.7×	38 0.7×	22	284
Nienke J. de Boer‐Veger Netherlands	9	261 1.1×	130 0.8×	26 0.4×	50 0.8×	26 0.5×	12	494

Countries citing papers authored by Dyson T. Wake

Since Specialization

Citations

This map shows the geographic impact of Dyson T. Wake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dyson T. Wake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dyson T. Wake more than expected).

Fields of papers citing papers by Dyson T. Wake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dyson T. Wake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dyson T. Wake. The network helps show where Dyson T. Wake may publish in the future.

Co-authorship network of co-authors of Dyson T. Wake

This figure shows the co-authorship network connecting the top 25 collaborators of Dyson T. Wake. A scholar is included among the top collaborators of Dyson T. Wake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dyson T. Wake. Dyson T. Wake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

David, Sean P., Henry M. Dunnenberger, Christopher Ward, et al.. (2023). Personalized medicine in a community health system: the NorthShore experience. Frontiers in Genetics. 14. 1308738–1308738. 7 indexed citations

Wake, Dyson T., et al.. (2022). Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review. Pharmacogenomics. 23(17). 933–948. 1 indexed citations

Bell, Gillian C., et al.. (2022). A clinician’s guide for counseling patients on results of a multigene pharmacogenomic panel. American Journal of Health-System Pharmacy. 79(19). 1634–1644. 6 indexed citations

Smith, D. Max, Dyson T. Wake, & Henry M. Dunnenberger. (2022). Pharmacogenomic Clinical Decision Support: A Scoping Review. Clinical Pharmacology & Therapeutics. 113(4). 803–815. 19 indexed citations

Saulsberry, Loren, Chris Ward, Dyson T. Wake, et al.. (2022). Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System. Journal of Personalized Medicine. 12(7). 1145–1145. 2 indexed citations

Wake, Dyson T., et al.. (2021). Synthesis of Major Pharmacogenomics Pretest Counseling Themes: A Multisite Comparison. Pharmacogenomics. 22(3). 165–176. 10 indexed citations

Wake, Dyson T., D. Max Smith, Sadaf Kazi, & Henry M. Dunnenberger. (2021). Pharmacogenomic Clinical Decision Support: A Review, How‐to Guide, and Future Vision. Clinical Pharmacology & Therapeutics. 112(1). 44–57. 43 indexed citations

Helseth, Donald L., Kamalakar Gulukota, Nicholas Miller, et al.. (2020). Flype: Software for enabling personalized medicine. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 187(1). 37–47. 6 indexed citations

Smith, D. Max, Kristin Weitzel, Amanda R. Elsey, et al.. (2019). CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genetics in Medicine. 21(8). 1842–1850. 105 indexed citations

10.

Wake, Dyson T., et al.. (2019). Pharmacogenomics. Medical Clinics of North America. 103(6). 977–990. 35 indexed citations

11.

Weitzel, Kristin, D. Max Smith, Amanda R. Elsey, et al.. (2018). Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned. Clinical and Translational Science. 11(2). 175–181. 30 indexed citations

12.

Lemke, Amy A., Peter J. Hulick, Dyson T. Wake, et al.. (2018). Patient Perspectives Following Pharmacogenomics Results Disclosure in an Integrated Health System. Pharmacogenomics. 19(4). 321–331. 39 indexed citations

13.

Lemke, Amy A., Christina G. Selkirk, Nicole Glaser, et al.. (2017). Primary Care Physician Experiences with Integrated Pharmacogenomic Testing in a Community Health System. Personalized Medicine. 14(5). 389–400. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact